Low Threshold Buprenorphine Induction at Harm Reduction Centers Grant

Low Threshold Buprenorphine Induction at Harm Reduction Centers Grant

Status: ACTIVE
Funder: State of New Jersey Department of Health
Amount: Approximately US $2,879,888
Last Updated: August 21, 2025

Summary

The Low Threshold Buprenorphine Induction at Harm Reduction Centers grant aims to enhance access to medication-assisted treatment in New Jersey. By supporting the State Opioid Response, it seeks to address the opioid crisis through effective prevention, treatment, and recovery services. This initiative is specifically available to five pre-selected agencies funded for Harm Reduction Centers, fostering collaboration to reduce unmet treatment needs and opioid-related deaths.

Overview

New Jersey Department of Health The scope of work for the public health system is ever-expanding, and the Department is on the frontlines in leading the response to public health challenges. The Department has three primary branches – Public Health Services, Health Systems, and Integrated Health. All work collaboratively toward improving health by strengthening New Jersey’s health system. Our Mission: Protect the public’s health, promote healthy communities, and continue to improve the quality of health care in New Jersey Low Threshold Buprenorphine Induction at Harm Reduction Centers Purpose for Which The Grant Program Funds Shall be Used To support the State Opioid Response (SOR) by conducting Low Threshold Buprenorphine Induction at Harm Reduction Centers (HRCs) that provide access to medication-assisted treatment (MAT), reduce unmet treatment need, and reducing opioid overdose related deaths through the provision of prevention, treatment and recovery activities for opioid use disorder.

Eligibility

You can learn more about this opportunity by visiting the funder's website. This grant program is only open to the five agencies who are currently funded for Harm Reduction Centers under DHST23HRC and DHST25OPE.